Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.61 |
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | MAOB | P27338 | 2/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | ELANE | P08246 | 9/20 | 0.59 |
| ▸ | CTSG | P08311 | 7/20 | 0.59 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.56 |
| ▸ | TTR | P02766 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22909075 | 0.83 | ALDH1A1 (0.62) | MAOAALDH1A1MAPTMAPK1HPGD | |
| SCHEMBL22820324 | 0.82 | BCL2 (0.61) | MAOAALDH1A1MAPTMAPK1HPGD | |
| Danthron SCHEMBL28102611 | 0.81 | MAPT (0.83) | MAOAALDH1A1MAPTMAPK1HPGD | |
| SCHEMBL22820129 | 0.80 | BCL2 (0.63) | MAOAALDH1A1MAPTMAPK1HPGD | |
| SCHEMBL16656217 | 0.80 | TTR (0.60) | MAOAALDH1A1MAPTMAPK1HPGD | |
| Quinalizarin SCHEMBL9308575 | 0.80 | MAOA (0.80) | MAOAALDH1A1MAPTMAPK1HPGD | |
| Anthrarufin SCHEMBL9308318 | 0.79 | MAPT (0.86) | MAOAALDH1A1MAPTMAPK1HPGD | |
| SCHEMBL6901176 | 0.79 | MAOA (0.77) | MAOAALDH1A1MAPTMAPK1HPGD | |
| SCHEMBL29929513 | 0.79 | MAOA (0.77) | MAOAALDH1A1MAPTMAPK1HPGD | |
| Anthrarufin SCHEMBL25355428 | 0.78 | MAOA (0.86) | MAOAALDH1A1MAPTMAPK1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127239-A1 | GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | SICHUAN UNIVERSITY (CN) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127239-A1 | GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | UGGT1, ALG8, FUT6 | MAOA 2119/4885ALDH1A1 689/4885MAPT 4692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.